Healthcare Stocks Mixed; Kythera Biopharma Roars to New 52-Week High After Double-Chin Treatment Succeeds in Tests

By
A A A

Top Healthcare Stocks

JNJ -0.19%

PFE -0.07%


ABT -0.38%

MRK -0.30%

AMGN -1.32%

Healthcare stocks are mixed this afternoon, with the NYSE Healthcare Sector Index rising about 0.2% while shares of healthcare companies in the S&P 500 slipping about 0.1 % as a group.

In company news, Kythera Biopharmaceuticals Inc ( KYTH ) is up nearly 25% at $41.85 a share, blowing past its former 52-week high to climb as high as $43.25 after saying its experimental injectable drug succeeded in reducing double chin in patients during late-stage studies.

Over 1000 patients with moderate to severe submental fat were tested in the two studies conducted in the United States and Canada, where ATX-101 was evaluated against a placebo and met both its main and secondary clinical goals.

In other sector news,

(+) CRL, (-0.17%) Initiated with a neutral rating at UBS and a $49 price target, citing valuation. The research firm also said there are early-stage signs of improvement at the laboratory-services company.

(-) RTMI, (-1.1%) FDA accepts Triferic as the trade name for the company's investigational drug to treat iron deficiency.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: KYTH

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

33,974,386
  • $17.98 ▲ 0.28%
20,763,901
  • $91.29 ▲ 2.06%
19,110,793
  • $7.26 ▼ 1.22%
18,528,869
    $8.33 unch
18,014,920
  • $4.19 ▼ 1.18%
16,448,919
  • $25.83 ▼ 0.19%
14,748,190
  • $7.60 ▼ 1.43%
14,144,383
  • $112.01 ▼ 0.47%
As of 12/24/2014, 02:12 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com